Bioavailability and Bioequivalence centers approved by DCGI India and CDSCO India for new drug approvals in INDIA. New Drug Formulations in India will require BA/BE study. The center has to be on the approved list. WHO PREAPPROVAL [Geneve] will also require BA/BE study.
Bioavailability and Bioequivalence centers approved by DCGI India and CDSCO India for new drug approvals in INDIA. New Drug Formulations in India will require BA/BE study. The center has to be on the approved list. WHO PREAPPROVAL [Geneve] will also require BA/BE study.
Bioavailability and Bioequivalence centers approved by DCGI India and CDSCO India for new drug approvals in INDIA. New Drug Formulations in India will require BA/BE study. The center has to be on the approved list. WHO PREAPPROVAL [Geneve] will also require BA/BE study.